Glaxo to buy Stiefel Labs for up to $3.6 billion

LONDON (Reuters) – GlaxoSmithKline Plc, the world’s second-largest drugmaker, has agreed to buy privately owned U.S. skincare specialist Stiefel Laboratories for up to $3.6 billion, the two companies said on Monday.

Leave a Reply